-
Mission Pharmacal begins promotion of Elestrin
SAN ANTONIO — Mission Pharmacal on Thursday announced that it has begun the promotion of Elestrin (estradiol gel) 0.06% in the United States through an agreement with Meda AB. The drug is a used as a topical hormone replacement gel to help treat hot flashes caused by menopause.
The addition of Elestrin both complements and expands Mission Pharmacal's existing line of products for women, which includes such products as prescription prenatal vitamins, a bone health product, anti-infectives, an iron supplement and a urinary analgesic.